You are here

About ABL Lyon

ABL is a CRO specialized in the evaluation of immunotherapies. ABL has the capabilities, expertise and quality systems in place to provide high quality immunomonitoring solutions to support preclinical and clinical studies.

Part of ABL Inc. since 2014, based in Lyon Gerland bio cluster, ABL is the partner of choice of several biotech and biopharmaceutical companies.

From immunogenicity prediction in the early stages of lead selection to large clinical trial immunomonitoring, from assay development to method validation & optimization, from few to several thousands of biological samples, ABL offers its scientific expertise, its high quality standards and its large technological platforms to support efficiently its customers in their product developments.